Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah E Kidd

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Pathology|August 29, 2016
Mycological testing of clinical samples in Australasian pathology laboratories: wide diversity and room for improvementArthur J Morris, Ian H Arthur, Sarah E Kidd, et al.
Pathology|March 4, 2026
Mycological testing in Australasian clinical mycology laboratories: survey of the current state and access to testingAdam G Stewart, Abby P Douglas, Sarah E Kidd, et al.
Pathology|August 5, 2022
Evaluation of a custom Sensititre YeastOne plate for susceptibility testing of isavuconazole and other antifungals against clinically relevant yeast and mould species in three Australian diagnostic mycology laboratoriesCatriona L Halliday, Kerry Weeks, Katarina Farac, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 28, 2017
Rates of Primary and Secondary Syphilis Among White and Black Non-Hispanic Men Who Have Sex With Men, United States, 2014Jeremy A Grey, Kyle T Bernstein, Patrick S Sullivan, et al.
Clinical Microbiology Reviews|March 29, 2024
Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infectionsChin Fen Neoh, Sharon C-A Chen, Fanny Lanternier, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2019
<i>cyp51A</i> Mutations, Extrolite Profiles, and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species ComplexJessica J Talbot, Jens C Frisvad, Jacques F Meis, et al.
Plos Neglected Tropical Diseases|March 6, 2023
Epidemiology, management and outcomes of Cryptococcus gattii infections: A 22-year cohortJennifer A O'Hern, Adrian Koenen, Sonja Janson, et al.
Lancet (London, England)|September 14, 2024
Beyond bacteria: the growing threat of antifungal resistanceNorman van Rhijn, Sevtap Arikan-Akdagli, Justin Beardsley, et al.
ASM Case Reports|January 8, 2026
<i>Trichosporon inkin</i> meningitis in a pediatric patient diagnosed via metagenomic sequencingKathryn Phillips, Karen P Acker, Jin-Young Han, et al.
International Journal of Antimicrobial Agents|August 27, 2016
Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendationsCatriona L Halliday, Sharon C-A Chen, Sarah E Kidd, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Pathology|August 29, 2016
Mycological testing of clinical samples in Australasian pathology laboratories: wide diversity and room for improvementArthur J Morris, Ian H Arthur, Sarah E Kidd, et al.
Pathology|March 4, 2026
Mycological testing in Australasian clinical mycology laboratories: survey of the current state and access to testingAdam G Stewart, Abby P Douglas, Sarah E Kidd, et al.
Pathology|August 5, 2022
Evaluation of a custom Sensititre YeastOne plate for susceptibility testing of isavuconazole and other antifungals against clinically relevant yeast and mould species in three Australian diagnostic mycology laboratoriesCatriona L Halliday, Kerry Weeks, Katarina Farac, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 28, 2017
Rates of Primary and Secondary Syphilis Among White and Black Non-Hispanic Men Who Have Sex With Men, United States, 2014Jeremy A Grey, Kyle T Bernstein, Patrick S Sullivan, et al.
Clinical Microbiology Reviews|March 29, 2024
Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infectionsChin Fen Neoh, Sharon C-A Chen, Fanny Lanternier, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2019
<i>cyp51A</i> Mutations, Extrolite Profiles, and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species ComplexJessica J Talbot, Jens C Frisvad, Jacques F Meis, et al.
Plos Neglected Tropical Diseases|March 6, 2023
Epidemiology, management and outcomes of Cryptococcus gattii infections: A 22-year cohortJennifer A O'Hern, Adrian Koenen, Sonja Janson, et al.
Lancet (London, England)|September 14, 2024
Beyond bacteria: the growing threat of antifungal resistanceNorman van Rhijn, Sevtap Arikan-Akdagli, Justin Beardsley, et al.
ASM Case Reports|January 8, 2026
<i>Trichosporon inkin</i> meningitis in a pediatric patient diagnosed via metagenomic sequencingKathryn Phillips, Karen P Acker, Jin-Young Han, et al.
International Journal of Antimicrobial Agents|August 27, 2016
Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendationsCatriona L Halliday, Sharon C-A Chen, Sarah E Kidd, et al.
Pageof 7